SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000886163-19-000157
Filing Date
2019-08-08
Accepted
2019-08-08 16:25:27
Documents
5
Effectiveness Date
2019-08-08

Document Format Files

Seq Description Document Type Size
1 S-8 lgnd-formsx8amendmentandre.htm S-8 152169
2 EXHIBIT 3.6 exhibit36.htm EX-3.6 11179
3 EXHIBIT 5.1 exhibit51opinionaugust2019.htm EX-5.1 16118
4 EXHIBIT 23.1 exhibit_231.htm EX-23.1 2907
5 exhibit51opinionaugus_image1.gif GRAPHIC 12383
  Complete submission text file 0000886163-19-000157.txt   200617
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-233130 | Film No.: 191009948
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1